Sanofi-Aventis Colon Cancer Drug Gets OK
617490
Sanofi-Synthelabo on Friday said it received Food and Drug Administration approval for its Eloxatin to be used with chemotherapy to treat stage 3 colon cancer.
626150
Merck & Co Inc. won U.S. approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.
751523
A new addition to an already successful drug promises good results for investors.
636079
New data presented today confirm that advanced lung cancer patients canlook forward to better-quality survival when treated with Alimta(R)(pemetrexed), a newly approved anticancer agent in the European Unioncompared with Taxotere(R) (docetaxel).
279186
WASHINGTON The first new cancer drug in ten years that is specifically designed to help children is a step closer to approval. An advisory panel at the Food and Drug Administration is recommending the use
667096
The biotech's new cancer candidate passes phase 1 trials.
531508
GAITHERSBURG, Maryland  - Data for Sanofi-Aventis' experimental bird flu vaccine support its safety and effectiveness for use in the event of a widespread outbreak, a U.S. advisory panel said on Tuesday.
695853
A conditional and limited approval of its cancer drug points to good news in a year of disappointments.
23668
An experimental Sanofi-Aventis diet  drug helped people lose much more weight than a placebo in an  eagerly anticipated two-year trial, researchers said on  Tuesday.
521788
GlaxoSmithKline's cervical cancer vaccine gets a positive recommendation.
39535
Sanofi-Aventis said on Friday that U.S. regulators had approved wider use for its colon cancer drug Eloxatin, lifting shares in the world's third-largest pharmaceuticals group.
243349
This lung cancer drug is not as effective as once hoped.
747218
Women with advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug made by GlaxoSmithKline PLC.
420195
Medarex's lead drug gets an important yet expected designation from the FDA.
725261
There's encouraging news about an enzyme replacement drug.
228084
FRIDAY, July 13 (HealthDay News) -- For patients battling advanced colorectal cancer, beginning treatment with a single chemotherapy drug is gentler than starting out with a combination of medicines and just as effective, according to two studies in the July 14  issue of The Lancet medical journal.
761698
Treatment with Wyeth's drug temsirolimus, which secured U.S. regulatory approval on Wednesday, extended survival for 3 1/2 months for patients with advanced renal-cell carcinoma, according to a company-sponsored study.